Authors: Ruhnau, KJ Meissner, HP Finn, JR Reljanovic, M Lobisch, M Schutte, K Nehrdich, D Tritschler, HJ Mehnert, H Ziegler, D

Citation: Kj. Ruhnau et al., Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy, DIABET MED, 16(12), 1999, pp. 1040-1043

Authors: Garwood, J Schnadelbach, O Clement, A Schutte, K Bach, A Faissner, A

Citation: J. Garwood et al., DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage, J NEUROSC, 19(10), 1999, pp. 3888-3899

Authors: Ziegler, D Hanefeld, M Rahnau, KJ Hasche, H Lobisch, M Schutte, K Kerum, G Malessa, R

Citation: D. Ziegler et al., Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid - A 7-month multicenter randomized controlled trial (ALADIN III Study), DIABET CARE, 22(8), 1999, pp. 1296-1301